More Orthocell Ltd news
Orthocell LtdASX: OCC

10th Patient Treatment Milestone in Human Tendon Study

May 17, 2018 at 12:17 AM EDT · Issued by Orthocell Ltd

Filed with ASX · May 17, 2018 at 12:17 AM EDT

On 6ix: 6ix.com/news/10th-patient-treatment-milestone-in-human-tendon-study

Orthocell Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Orthocell Ltd on 6ix

Story so far

  • 50% Patient Treatment Milestone in Human Nerve TrialJan 2, 2018
  • Early Positive Results for CelGro in Human Tendon StudyJun 16, 2016
  • Approval for Human Tendon Study Using Celgro ReceivedMar 30, 2016

Earlier from Orthocell

  • Orthocell Extends Distributor Network in the EUMay 7, 2018
  • Orthocell Announces Successful Bone Repair Study ResultsApr 30, 2018
  • Orthocell Appoints First Distributor in the EUApr 29, 2018
  • New Cell Factory Patent Granted in the USFeb 21, 2018
  • Positive CelGro Study Results in ACL ReconstructionFeb 4, 2018

Later from Orthocell

  • First Product Use and Sale of CelGro in EuropeMay 21, 2018
  • Orthocell Secures CelGro Patent Protection in EuropeMay 24, 2018
  • First Product Use and Sales of CelGro in PolandMay 30, 2018
  • Orthocell Announces Successful Tendon Study ResultsJun 6, 2018
  • Orthocell Announces Successful Ortho-ATI Study ResultsJun 13, 2018
All Orthocell news releases↗

Follow Orthocell into a list and get an email when it puts out news.

Follow Orthocell
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer